Bicocca Open Archive

Logo unimib boa
PIAZZA, FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.600
AS - Asia 7.222
EU - Europa 6.869
SA - Sud America 952
Continente sconosciuto - Info sul continente non disponibili 857
AF - Africa 167
OC - Oceania 56
Totale 26.723
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.007
IT - Italia 2.340
SG - Singapore 2.061
CN - Cina 1.500
VN - Vietnam 1.461
HK - Hong Kong 801
DE - Germania 712
BR - Brasile 654
RU - Federazione Russa 630
SE - Svezia 527
CA - Canada 476
GB - Regno Unito 468
FR - Francia 395
IE - Irlanda 392
UA - Ucraina 270
JP - Giappone 256
BD - Bangladesh 229
ES - Italia 201
IN - India 200
NL - Olanda 191
FI - Finlandia 168
AT - Austria 132
KR - Corea 125
TR - Turchia 125
AR - Argentina 119
CH - Svizzera 74
PL - Polonia 74
BE - Belgio 67
MX - Messico 64
DK - Danimarca 62
ID - Indonesia 61
IQ - Iraq 58
AU - Australia 50
TW - Taiwan 50
CL - Cile 48
ZA - Sudafrica 43
EC - Ecuador 37
PK - Pakistan 37
PH - Filippine 33
SA - Arabia Saudita 33
GR - Grecia 32
IR - Iran 32
PT - Portogallo 31
VE - Venezuela 29
CO - Colombia 28
TH - Thailandia 23
MA - Marocco 21
UZ - Uzbekistan 21
NO - Norvegia 20
TN - Tunisia 17
AE - Emirati Arabi Uniti 16
MY - Malesia 16
KE - Kenya 14
OM - Oman 14
PE - Perù 14
PY - Paraguay 14
RE - Reunion 13
CR - Costa Rica 12
EG - Egitto 12
SI - Slovenia 11
ET - Etiopia 10
LT - Lituania 10
JO - Giordania 9
LB - Libano 9
NP - Nepal 9
RO - Romania 9
CI - Costa d'Avorio 8
DZ - Algeria 8
JM - Giamaica 8
IL - Israele 7
AL - Albania 6
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
HN - Honduras 6
NZ - Nuova Zelanda 6
PA - Panama 6
RS - Serbia 6
UY - Uruguay 6
BB - Barbados 5
BG - Bulgaria 5
BH - Bahrain 5
BY - Bielorussia 5
EU - Europa 5
KZ - Kazakistan 5
MT - Malta 5
SY - Repubblica araba siriana 5
KG - Kirghizistan 4
PS - Palestinian Territory 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
HU - Ungheria 3
KW - Kuwait 3
LU - Lussemburgo 3
MD - Moldavia 3
MK - Macedonia 3
UG - Uganda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
GH - Ghana 2
Totale 25.837
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.468
Singapore 1.242
Ashburn 834
Milan 803
Hong Kong 774
San Jose 609
Woodbridge 490
Ho Chi Minh City 445
Houston 368
Dublin 366
Hanoi 360
Frankfurt am Main 332
Chandler 309
Jacksonville 301
New York 284
Santa Clara 276
Wilmington 272
Toronto 253
Fairfield 228
Dearborn 207
Los Angeles 201
Chicago 187
Council Bluffs 184
Rome 181
Beijing 172
Dallas 164
Princeton 146
The Dalles 145
Hefei 144
Seattle 134
Nanjing 115
Columbus 108
Vienna 101
Cambridge 94
Munich 94
Seoul 88
Lauterbourg 86
São Paulo 83
Shanghai 81
Helsinki 77
Buffalo 75
Boardman 73
Moscow 65
Tokyo 62
Guangzhou 60
London 60
Lachine 56
Sesto San Giovanni 55
Madrid 50
Orem 48
Da Nang 47
Atlanta 43
Jakarta 43
Barcelona 42
Bologna 42
Amsterdam 41
Paris 41
Montreal 40
Lawrence 39
Dong Ket 37
Haiphong 37
Istanbul 37
Warsaw 37
Denver 36
Santiago 36
Boston 35
Rio de Janeiro 35
Nanchang 34
Baghdad 33
Naples 32
Altamura 31
Brooklyn 31
Brussels 31
Turin 31
Shenyang 30
Florence 28
Hải Dương 28
Boydton 27
Ha Long 27
Bari 26
Chennai 26
Jinan 25
Nuremberg 25
San Diego 25
Washington 25
Croydon 24
Hangzhou 24
St Louis 24
Andover 23
Berlin 23
Chengdu 23
Hiroshima 23
Hyderabad 23
Can Tho 22
Figino 22
Tianjin 22
Biên Hòa 21
Changsha 21
Falls Church 21
Kent 21
Totale 14.930
Salva come PNG Salva come JPEG
Nome #
Diagnosis and management of cerebral amyloid angiopathy: a scientific statement from the International CAA Association and the World Stroke Organization 2.962
Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers? 721
Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease 572
Validation of clinicoradiological criteria for the diagnosis of cerebral amyloid angiopathy-related inflammation 531
Anti-Aβ autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies 530
Feasibility of a standard cognitive assessment in European academic memory clinics 507
The Italian guideline on diagnosis and treatment of dementia and mild cognitive impairment 496
Spontaneous Non-Aneurysmal Convexity Subarachnoid Hemorrhage: A Scoping Review of Different Etiologies beyond Cerebral Amyloid Angiopathy 478
Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis 457
The efficacy of cognitive stimulation, cognitive training, and cognitive rehabilitation for people living with dementia: a systematic review and meta-analysis 429
Clinical, biological and neuroradiological evolution of Cerebral Amyloid Angiopathy-related inflammation: the iCAβ International Network longitudinal study. 428
Anti-Aβ autoantibodies in amyloid related imaging abnormalities (ARIA): Candidate biomarker for immunotherapy in Alzheimer's disease and cerebral amyloid angiopathy 419
Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease 380
Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients? 367
Iatrogenic CAA-ri supported by ARIA-E, raised CSF anti-Aβ autoantibodies and sTREM2 after COVID-19 vaccination 354
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 346
Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation 327
Cerebral Amyloid Angiopathy-Related Inflammation 318
Prodromal Alzheimer's Disease Presenting as Cerebral Amyloid Angiopathy-Related Inflammation with Spontaneous Amyloid-Related Imaging Abnormalities and High Cerebrospinal Fluid Anti-Aβ Autoantibodies 309
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-A beta auto-antibodies 304
Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy–Related Inflammation: A Multicenter Prospective Longitudinal Cohort Study 303
Increased Soluble APPalpha, Abeta 1-42, and Anti-Abeta 1-42 Antibodies in Plasma From Down Syndrome Patients 302
Spontaneous and iatrogenic ARIA: Mechanistic insights from CAA‐related inflammation 302
Idiopathic infratentorial superficial siderosis of the central nervous system: case report and review of literature 300
Cholinesterase inhibitor use is associated with increased plasma levels of anti-Aβ 1-42 antibodies in Alzheimer's disease patients 285
Ricerca quantitativa di Epstein-barr virus in campioni di liquor e sangue da pazienti affetti da sclerosi multipla 285
Positron Emission Tomography in Cerebral Amyloid Angiopathy: A Scoping Review 284
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study 269
Neuroactive Steroid Levels are Modified in Cerebrospinal Fluid and Plasma of Post-Finasteride Patients Showing Persistent Sexual Side Effects and Anxious/Depressive Symptomatology 268
Validation of Clinical-Radiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-related Inflammation 261
Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia 258
Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of Vascular Professional Interest Area (PIA), updates in 2022-2023. Cerebrovascular disease and the failure of elimination of Amyloid-β from the brain and retina with age and Alzheimer's disease: Opportunities for therapy 256
Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency 255
Pathogenetic role of anti-AB autoantibodies in Cerebral Amyloid Angiopathy-related inflammation and Alzheimer's disease 255
Biological markers of vascular damage in Alzheimer’s disease patients 254
A challenging diagnosis of reversible “vascular” dementia: Cerebral amyloid angiopathy-related inflammation 250
Association of Microglial Activation With Spontaneous ARIA-E and Cerebrospinal Fluid Levels of Anti-Aβ Autoantibodies 248
Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease 243
Abrupt withdrawal of immunosuppressive drugs: a potential trigger for CAA-ri 241
Ubiquitin regulates GGA3-mediated degradation of BACE1 239
Discovering the Italian phenotype of cerebral amyloid angiopathy (CAA): the SENECA project 238
Anti-Aβ autoantibodies in CAA-ri vs AD patients: different singers for the same ARIA? 236
Anti-Abeta autoantibodies in cerebral amyloid angiopathy related inflammation: a role for pathogenesis? 236
Recurrence of Cerebral Amyloid Angiopathy-Related Inflammation: A Report of Two Cases from the iCAβ International Network 230
Clinical and Neuroradiological Manifestations of Cerebral Amyloid Angiopathy: A Closer Look into the Natural History of a Frequent Disease 223
CSF biomarkers for Amyloid Related Imaging Abnormalities (ARIA) in immunotherapy trials of Alzheimer’s disease and Cerebral Amyloid Angiopathy: report from the iCAß International Network 222
Anti-Aß autoantibodies in cerebral amyloid angiopathy-related inflammation: a human spontaneous model of amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease 218
Microbiota-gut-brain axis dysregulation in Alzheimer’s disease and its modulation through probiotic supplementation 212
Reader response: A phase 3 trial of IV immunoglobulin for Alzheimer disease 211
Anti-abeta antibodies in CSF: markers for therapies? 208
Metodo e kit per la rilevazione di anticorpi 206
BACE1 Protein Endocytosis and Trafficking Are Differentially Regulated by Ubiquitination at Lysine 501 and the Di-leucine Motif in the Carboxyl Terminus. 203
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-Aβ auto-antibodie 201
Author Response: Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy–Related Inflammation: A Multicenter Prospective Longitudinal Cohort Study 199
The Second Insubria Autumn School on Neuroimmune Pharmacology: Repurposing Established Drugs for Novel Indications 198
Biomarkers in cerebral amyloid angiopathy-related inflammation 197
Increased levels of tissue factor pathway inhibitor in cerebrospinal fluid are related to neurodegeneration in alzheimer’s disease patients 196
Cerebral Amyloid Angiopathy-Related Inflammation: Report of a Case with Very Difficult Therapeutic Management 195
Analytical Validation of a pre-Industrial Prototype Assay for Anti-Aβ Autoantibody ultrasensitive quantification in patients with CAA-ri and ARIA-E of Alzheimer’s disease Immunotherapy 193
Hemostasis components in cerebral amyloid angiopathy and Alzheimer’s disease 191
Pathogenetic similarities shared by Alzheimer's disease and multiple sclerosis 186
Effect of TNF-alpha on platelet glutamate uptake in Stroke patients 184
Traumatic Brain Injury and Chronic Traumatic Encephalopathy: Not Only Trigger for Neurodegeneration but Also for Cerebral Amyloid Angiopathy? 183
Platelets might mediate the increase of plasma glutamate in acute ischemic stroke: Relevance for early neurological deterioration 178
CSF anti-Aß autoantibodies as novel biomarker for Cerebral Amyloid Angiopathy-related inflammation: implications for amyloid-related imaging abnormalities (ARIA) during passive immunization in Alzheimer’s disease 177
Anti-AB autoantibodies and endothelial damage during amyloid-related imaging abnormalities (ARIA): report from the Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's disease Biomarkers Collaborative Network 177
Autologous anti-Aß antibodies in caa-ri: new biomarker for detection of Amyloid-Related Imaging Abnormalities (ARIA) during Aß-disease modifying therapies for AD 176
Symposium Immunotherapy Trials in CAA and AD: The ARIA paradox in AD and CAA: merely an adverse event or an out of tune proof of immunotherapy effectiveness? 175
CAA-ri and ARIA: Two Faces of the Same Coin? 168
Neurovascular Manifestations of Iron-Deficient Anemia: Narrative Review and Practical Reflections through a Teaching Case 168
Anti-Aß autoantibodies and endothelial damage during amyloid-related imaging abnormalities (ARIA): report from the Inflammatory Cerebral Amyloid Angiopathy and Alzheimer’s disease βiomarkers Collaborative Network (iCAβ) 168
Anti-Aβ autoantibodies in cerebral amyloid angiopathy-related inflammation: a human spontaneous model of amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease 167
A method and a kit for the detection of anti-beta amyloid antibodies 166
Pathogenetic Role of Anti- Aß Autoantibodies in CAA-related Inflammation: Implications for Amyloid-modifying Therapies in AD 165
Inflammatory CAA and AD Biomarkers International Network 165
Non-vascular leucoencephalic dementia: The case of Cerebral Amyloid Angiopathy related inflammation 163
Anti-Amyloid Treatments: A Therapeutic Revolution, Ready for Europe 161
Large Collaborative Registries and Real-World Data to Manage Amyloid-Related Imaging Abnormalities 161
Progress in the Treatment of Alzheimer’s Disease Is Needed – Position Statement of European Alzheimer’s Disease Consortium (EADC) Investigators 156
Natural amyloid-beta oligomers acutely impair the formation of a contextual fear memory in mice 155
Cerebral amyloid angiopathy-related inflammation. report of a case 155
Auto-antibodies to Aß in CSF 151
Cerebrospinal Fluid Anti-Amyloid-Beta; Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation 150
The Venular Side of Cerebral Amyloid Angiopathy: Proof of Concept of a Neglected Issue 149
Vascular damage and neurodegeneration 149
In silico exploration of amyloid-related imaging abnormalities in the gantenerumab open-label extension trials using a semi-mechanistic model 149
Clearance of interstitial fluid (ISF) and CSF (CLIC) group—part of Vascular Professional Interest Area (PIA) 145
Advancing dementia care: a review of Italy's public health response within the WHO Global Action Plan and European strategies 141
Why does ARIA‐E appear bright? A quantitative model linking brain tissue composition and T2 FLAIR hyperintensities 140
Données récentes sur l’Amyloïdose Cérébrale Inflammatoire. 136
Monoclonal antibodies for early Alzheimer disease: a long road to discovery and marketing approval, a short timeline for health systems to organise services 135
Inflammatory CAA mechanisms and biomarkers– lessons for sporadic CAA diagnosis and treatment 125
Anti-Aß autoantibodies and endothelial damage during spontaneous Amyloid-Related Imaging Abnormalities (ARIA): report from the inflammatory cerebral amyloid angiopathy and alzheimer's disease biomarkers collaborative network (iCAB) 124
The inflammatory Cerebral Amyloid Angiopathy and Alzheimer’s disease Biomarkers International Network (iCAβ) initiative 123
Cerebrospinal Fluid Biomarkers Profiling in Cerebral Amyloid Angiopathy and Relationship With Disease Phenotypes 112
Abstract W MP89: Validation of Clinical-Radiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-related Inflammation 109
Spontaneous and Drug-Induced Amyloid-Related Imaging Abnormalities: Overlaps, Divergences, and Clinical Implications Across a Continuum Between Alzheimer’s Disease and Cerebral Amyloid Angiopathy 99
Iatrogenic cerebral amyloid angiopathy and cerebral amyloid angiopathy-related inflammation: clinical, radiological and biological findings from a case 71
Mechanisms of Dural Involvement in Cerebral Amyloid Angiopathy 64
The Inflammatory Side of Iatrogenic Cerebral Amyloid Angiopathy: Rethinking Therapeutic Opportunities 63
Totale 26.695
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.976
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.976
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022943 0 86 114 97 74 106 33 31 42 76 74 210
2022/20231.727 204 419 146 146 147 232 96 91 172 16 37 21
2023/20241.316 44 67 59 62 180 274 229 82 133 32 39 115
2024/20253.696 164 421 317 135 297 179 277 202 382 463 291 568
2025/202612.138 1.434 862 773 1.136 1.207 791 1.452 747 1.066 943 703 1.024
2026/20271.406 604 802 0 0 0 0 0 0 0 0 0 0
Totale 26.723